leflunomide has been researched along with uridine in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 14 (46.67) | 18.2507 |
2000's | 13 (43.33) | 29.6817 |
2010's | 3 (10.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Caulfield, JP; Cherwinski, HM; Cheung, P; Cohn, RG; Nakano, G; Ransom, JT; Webster, DJ; Xu, YZ; Young, JM | 1 |
Bartlett, RR; Müller, S; Zeitter, D; Zielinski, T | 1 |
Cao, W; Morris, RE; Nair, RV | 2 |
Chong, AS; Finnegan, A; Gong, H; Williams, JW; Xu, X | 1 |
Cao, W; Morris, RE; Shorthouse, R; Silva, HT | 1 |
Groth, CG; Karlsson-Parra, A; Korsgren, O; Liu, J; Rafael, E; Sundberg, B; Wennberg, L; Zhu, S | 1 |
Blinder, L; Chong, AS; Finnegan, A; Gong, H; Shen, J; Williams, JW; Xu, X | 1 |
Blinder, L; Chong, AS; Gong, H; Shen, J; Williams, JW; Xu, X | 1 |
Chong, AS; Finnegan, A; Gong, H; Jäck, HM; Siemasko, K; Williams, JW | 1 |
Carrey, EA; Fairbanks, LD; Hawrylowicz, CM; Kirschbaum, B; Richards, DF; Rückemann, K; Simmonds, HA | 1 |
Amano, Y; Kitagawa, H; Mizushima, Y; Ogata, K | 1 |
Blinder, L; Chong, AS; Clardy, C; Foster, P; Huang, W; Liu, W; Luo, J; Ma, L; Shen, J; Williams, JA; Xiao, F; Xu, W; Xu, X | 1 |
Blinder, L; Chong, AS; Knight, DA; Lurain, NS; Miller, DM; Sedmak, DD; Shen, J; Waldman, WJ; Williams, JW | 1 |
Aggarwal, BB; Manna, SK; Mukhopadhyay, A | 1 |
Fehr, T; Ochsenbein, AF; Pinschewer, DD; Zinkernagel, RM | 1 |
Bickerstaff, A; Gordillo, G; Knight, DA; Orosz, CG; Orosz, K; Waldman, WJ | 1 |
Collins, M; Graves, LM; Huang, M; Mitchell, BS; Wang, Y | 1 |
Mall, JW; Myers, JA; Philipp, AW; Pollmann, C; Saclarides, TJ; Xu, X | 1 |
Jung, S; Korn, T; Magnus, T; Toyka, K | 1 |
Aringer, M; Eselböck, D; Grisar, J; Köller, MD; Pietschmann, P; Smolen, JS; Steiner, CW; Stummvoll, GH; Wagner, L; Zierhut, B; Zwölfer, B | 1 |
Stuhlmeier, KM | 1 |
Chong, AS; Knight, DA; Meister, GT; Shen, J; Waldman, WJ; Williams, JW; Zeng, H | 1 |
Guerne, PA; Magne, D; Mézin, F; Palmer, G | 1 |
Nakayamada, S; Ra, C; Saito, K; Sawamukai, N; Tanaka, Y; Yamaoka, K | 1 |
Adam, C; Baumann, P; Bumeder, I; Mandl-Weber, S; Oduncu, F; Schmidmaier, R; Völkl, A | 1 |
Fukushima, R; Hirashiba, M; Hishikawa, A; Kanamori, S; Kaneto, M; Kitagawa, H; Muranaka, R | 1 |
Jang, HS; Kerkvliet, NI; Koch, DC; Kolluri, SK; Kopparapu, PR; O'Donnell, EF; Phillips, JL; Tanguay, RL | 1 |
30 other study(ies) available for leflunomide and uridine
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
The immunosuppressant leflunomide inhibits lymphocyte proliferation by inhibiting pyrimidine biosynthesis.
Topics: Animals; Cell Cycle; Cell Nucleolus; Cells, Cultured; Dihydroorotate Dehydrogenase; DNA; Enzyme Inhibitors; Female; Humans; Immunosuppressive Agents; Isoxazoles; Ki-67 Antigen; Leflunomide; Lymphocyte Activation; Neoplasm Proteins; Nuclear Proteins; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Proliferating Cell Nuclear Antigen; Pyrimidines; Rats; RNA; T-Lymphocytes; Uridine | 1995 |
Leflunomide, a reversible inhibitor of pyrimidine biosynthesis?
Topics: Cell Division; Cell Line; Cytidine; Humans; Immunosuppressive Agents; Isoxazoles; Kinetics; Leflunomide; Pyrimidines; Uracil Nucleotides; Uridine | 1995 |
Inhibition of smooth muscle cell proliferation in vitro by leflunomide, a new immunosuppressant, is antagonized by uridine.
Topics: Aniline Compounds; Animals; Cell Division; Cell Line; Crotonates; Fibroblast Growth Factor 2; Growth Inhibitors; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mice; Muscle, Smooth; Nitriles; Toluidines; Uridine | 1995 |
Inhibition of smooth muscle cell proliferation in vitro by leflunomide, a new immunosuppressant, is antagonized by uridine.
Topics: Aniline Compounds; Animals; Cell Division; Cell Line, Transformed; Crotonates; Graft Rejection; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mice; Muscle, Smooth; Nitriles; Toluidines; Uridine | 1995 |
Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation.
Topics: Animals; Blotting, Western; Dose-Response Relationship, Drug; Immunosuppressive Agents; Isoxazoles; Leflunomide; Leukemia, Experimental; Mice; Protein-Tyrosine Kinases; Tumor Cells, Cultured; Uridine | 1996 |
Mechanism of action of leflunomide: in vivo uridine administration reverses its inhibition of lymphocyte proliferation.
Topics: Animals; Dihydroorotate Dehydrogenase; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Male; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Rats; Rats, Inbred Lew; Thymidine; Uridine | 1996 |
Efficacy of immunosuppressive drugs in islet xenotransplantation: leflunomide in combination with cyclosporine and mycophenolate mofetil prevents islet xenograft rejection in the pig-to-rat model.
Topics: Animals; Antibodies; Complement System Proteins; Cyclosporine; Drug Interactions; Drug Therapy, Combination; Female; Graft Rejection; Immunoglobulin G; Immunohistochemistry; Immunosuppressive Agents; Islets of Langerhans; Islets of Langerhans Transplantation; Isoxazoles; Leflunomide; Male; Mice; Pregnancy; Rats; Swine; Time Factors; Transplantation, Heterologous; Uridine | 1997 |
In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice.
Topics: Aniline Compounds; Animals; Autoimmune Diseases; Crotonates; Dihydroorotate Dehydrogenase; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymph Nodes; Lymphoproliferative Disorders; Mice; Mice, Mutant Strains; Nitriles; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Pyrimidine Nucleotides; Toluidines; Uridine | 1997 |
Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: mechanisms of action.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Biphenyl Compounds; Cytidine Triphosphate; Female; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphoproliferative Disorders; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Phosphorylation; Tyrosine; Uridine; Uridine Triphosphate | 1997 |
Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production.
Topics: Animals; B-Lymphocytes; Binding, Competitive; DNA-Binding Proteins; Growth Inhibitors; Immunoglobulin G; Immunosuppressive Agents; Interleukin-4; Isoxazoles; Janus Kinase 3; Leflunomide; Lipopolysaccharides; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Phosphorylation; Protein-Tyrosine Kinases; Signal Transduction; STAT6 Transcription Factor; Trans-Activators; Tyrosine; Uridine | 1998 |
Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans.
Topics: Adenosine Triphosphate; Adjuvants, Immunologic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biphenyl Compounds; Chromatography, High Pressure Liquid; Dihydroorotate Dehydrogenase; Humans; Immunosuppressive Agents; In Vitro Techniques; Isoxazoles; Leflunomide; Lymphocyte Activation; Mice; Mitogens; Oxidoreductases; Oxidoreductases Acting on CH-CH Group Donors; Phytohemagglutinins; Pyrimidines; T-Lymphocytes; Uridine; Uridine Triphosphate | 1998 |
Oral administration of leflunomide (HWA486) results in prominent suppression of immunoglobulin E formation in a rat type 1 allergy model.
Topics: Administration, Oral; Aniline Compounds; Animals; Antibody Specificity; Crotonates; Disease Models, Animal; Drug Administration Schedule; Female; Hydroxybutyrates; Hypersensitivity, Immediate; Immunoglobulin E; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocyte Activation; Nitriles; Ovalbumin; Rats; Rats, Inbred BN; Toluidines; Uridine | 1999 |
In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression.
Topics: Aniline Compounds; Animals; Cricetinae; Crotonates; Graft Rejection; Heart Transplantation; Humans; Hydroxybutyrates; Immunosuppressive Agents; Isoxazoles; Leflunomide; Liver; Lymph Nodes; Mesocricetus; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Nitriles; Pyrimidine Nucleotides; Rats; Rats, Inbred Lew; Spleen; Toluidines; Transplantation, Heterologous; Transplantation, Homologous; Uridine | 1999 |
Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide.
Topics: Animals; Antiviral Agents; Cells, Cultured; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Drug Resistance, Microbial; Drug Resistance, Multiple; Endothelium, Vascular; Fibroblasts; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Rats; Uridine | 1999 |
Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis.
Topics: Apoptosis; Caspase Inhibitors; Caspases; Cells, Cultured; Cytotoxicity, Immunologic; DNA-Binding Proteins; Enzyme Activation; Gene Expression Regulation; Genes, Reporter; Growth Inhibitors; HeLa Cells; Humans; I-kappa B Kinase; I-kappa B Proteins; Immunosuppressive Agents; Isoxazoles; JNK Mitogen-Activated Protein Kinases; Jurkat Cells; Leflunomide; Lipid Peroxidation; Mitogen-Activated Protein Kinases; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Receptors, Tumor Necrosis Factor; Signal Transduction; Transcription Factor AP-1; Tumor Necrosis Factor-alpha; Uridine | 2000 |
Leflunomide-mediated suppression of antiviral antibody and Tcell responses: differential restoration by uridine.
Topics: Animals; Antibodies, Viral; Antibody Formation; Autoimmune Diseases; CD8-Positive T-Lymphocytes; Diabetes Mellitus; Dose-Response Relationship, Drug; Immunosuppressive Agents; Isoxazoles; Leflunomide; Lymphocytic choriomeningitis virus; Mice; Mice, Inbred C57BL; Mice, Transgenic; T-Lymphocytes; T-Lymphocytes, Cytotoxic; Uridine; Vesicular stomatitis Indiana virus | 2001 |
Inhibition of angiogenesis-related endothelial activity by the experimental immunosuppressive agent leflunomide.
Topics: Angiogenesis Inhibitors; Animals; Cell Division; Cells, Cultured; Culture Media; Cyclosporine; Endothelium, Vascular; Humans; Isoxazoles; Leflunomide; Mice; Microcirculation; Models, Animal; Tacrolimus; Umbilical Veins; Uridine | 2001 |
A77 1726 induces differentiation of human myeloid leukemia K562 cells by depletion of intracellular CTP pools.
Topics: Aniline Compounds; Anti-Inflammatory Agents, Non-Steroidal; Aspartate Carbamoyltransferase; Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); Cell Cycle Proteins; Cell Differentiation; Cell Division; Crotonates; Cytidine; Cytidine Triphosphate; Dihydroorotase; Drug Interactions; Gene Expression; Glycophorins; Humans; Hydroxybutyrates; Isoxazoles; K562 Cells; Leflunomide; Multienzyme Complexes; Nitriles; Pyrimidines; S Phase; Toluidines; Uridine; Uridine Triphosphate | 2002 |
[Leflunomide reduces the angiogenesis score and tumor growth of subcutaneously implanted colon carcinoma cells in the mouse model].
Topics: Administration, Oral; Animals; Capillaries; Cell Division; Colonic Neoplasms; HT29 Cells; Humans; Injections, Intraperitoneal; Isoxazoles; Leflunomide; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Random Allocation; Uridine | 2002 |
Modulation of effector cell functions in experimental autoimmune encephalomyelitis by leflunomide--mechanisms independent of pyrimidine depletion.
Topics: Adoptive Transfer; Animals; Animals, Newborn; Antigens, CD; B7-2 Antigen; Cells, Cultured; Chemotaxis, Leukocyte; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Guinea Pigs; Immunosuppressive Agents; Interferon-gamma; Interleukin-10; Interleukin-2; Isoxazoles; Leflunomide; Membrane Glycoproteins; Microglia; Multiple Sclerosis; Myelin Basic Protein; Pyrimidines; Rats; Rats, Inbred Lew; STAT6 Transcription Factor; T-Lymphocytes, Helper-Inducer; Trans-Activators; Uridine | 2004 |
Leflunomide inhibits transendothelial migration of peripheral blood mononuclear cells.
Topics: Antirheumatic Agents; Cell Adhesion; Cell Movement; Cells, Cultured; Chemotaxis, Leukocyte; Endothelium, Vascular; Flow Cytometry; Humans; Hyaluronic Acid; Isoxazoles; Leflunomide; Leukocytes, Mononuclear; Methotrexate; Uridine | 2004 |
Effects of leflunomide on hyaluronan synthases (HAS): NF-kappa B-independent suppression of IL-1-induced HAS1 transcription by leflunomide.
Topics: Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Enzyme Repression; Fibroblasts; Glucuronosyltransferase; Humans; Hyaluronan Synthases; Hyaluronic Acid; Immunosuppressive Agents; Interleukin-1; Isoxazoles; Leflunomide; NF-kappa B; Protein Transport; Pyrimidines; RNA, Messenger; Synovial Membrane; Transcription, Genetic; Uridine | 2005 |
Concurrent antiviral and immunosuppressive activities of leflunomide in vivo.
Topics: Animals; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Graft Rejection; Heart; Heart Transplantation; Immunosuppressive Agents; Isoxazoles; Lectins, C-Type; Leflunomide; Lung; Rats; Rats, Inbred Lew; Salivary Glands; Spleen; Transplants; Uridine; Viral Proteins | 2006 |
The active metabolite of leflunomide, A77 1726, increases proliferation of human synovial fibroblasts in presence of IL-1beta and TNF-alpha.
Topics: Aniline Compounds; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cell Proliferation; Cells, Cultured; Crotonates; Drug Synergism; Enzyme Inhibitors; Fibroblasts; Humans; Hydroxybutyrates; Interleukin-1beta; Isoxazoles; Jurkat Cells; Leflunomide; Nitriles; Prostaglandin-Endoperoxide Synthases; Protein-Tyrosine Kinases; Synovial Membrane; Toluidines; Tumor Necrosis Factor-alpha; Uridine | 2006 |
Leflunomide inhibits PDK1/Akt pathway and induces apoptosis of human mast cells.
Topics: Aniline Compounds; Apoptosis; Arthritis, Rheumatoid; Cell Survival; Cells, Cultured; Chronic Disease; Crotonates; Dihydroorotate Dehydrogenase; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Humans; Hydroxybutyrates; Immunosuppressive Agents; Inflammation Mediators; Isoxazoles; Leflunomide; Mast Cells; Nitriles; Oxidoreductases Acting on CH-CH Group Donors; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Signal Transduction; Synovial Membrane; Synovitis; Toluidines; Uridine | 2007 |
Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Cell Adhesion Molecules; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Culture Media; Dihydroorotate Dehydrogenase; Down-Regulation; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; G1 Phase; Humans; Isoxazoles; Leflunomide; Multiple Myeloma; Oxidoreductases Acting on CH-CH Group Donors; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Receptors, Cytokine; Ribosomal Protein S6 Kinases, 70-kDa; Stromal Cells; Uridine | 2009 |
Inhibiting the teratogenicity of the immunosuppressant leflunomide in mice by supplementation of exogenous uridine.
Topics: Abnormalities, Drug-Induced; Animals; Dihydroorotate Dehydrogenase; Embryonic Development; Female; Fetal Viability; Fetus; Immunosuppressive Agents; Isoxazoles; Leflunomide; Mice; Mice, Inbred ICR; Oxidoreductases Acting on CH-CH Group Donors; Pregnancy; Pyrimidine Nucleotides; Teratogens; Uridine | 2009 |
The aryl hydrocarbon receptor mediates leflunomide-induced growth inhibition of melanoma cells.
Topics: Aniline Compounds; Cell Line, Tumor; Cell Proliferation; Crotonates; Cyclin-Dependent Kinase Inhibitor p21; Dihydroorotate Dehydrogenase; Fluoresceins; Gene Knockdown Techniques; Humans; Hydroxybutyrates; Isoxazoles; Leflunomide; Melanoma; Nitriles; Oxidoreductases Acting on CH-CH Group Donors; Proto-Oncogene Proteins c-myc; Receptors, Aryl Hydrocarbon; Signal Transduction; Succinimides; Toluidines; Uridine | 2012 |